Provided by Tiger Fintech (Singapore) Pte. Ltd.

HeartSciences Inc

3.72
-0.1372-3.56%
Post-market: 3.720.00000.00%19:49 EDT
Volume:51.87K
Turnover:201.02K
Market Cap:4.02M
PE:-0.36
High:4.07
Open:3.96
Low:3.65
Close:3.86
Loading ...

Heartsciences Receives FDA Breakthrough Device Designation for Myovista Insights AI-Ecg Algorithm for Detecting Aortic Stenosis

THOMSON REUTERS
·
04 Jun

HeartSciences Inc. Receives FDA Breakthrough Device Designation for AI-ECG Algorithm Detecting Aortic Stenosis

Reuters
·
04 Jun

Heartsciences Inc. Amends Bylaws to Designate Series D Preferred Stock

Reuters
·
04 Jun

HeartSciences Inc. Secures Foundational US Patent for AI-Driven ECG Assessment, Expanding Its Robust IP Portfolio

Reuters
·
03 Jun

BRIEF-HeartSciences Signs First MyoVista Insights™ Platform Customer

Reuters
·
29 May

Heartsciences: Signs First Commercial Customer for Myovista Insights™ Platform Called Westcliffe Health Innovations, Based in UK

THOMSON REUTERS
·
29 May

Heartsciences Inc. Announces Bylaw Amendments for Series D Convertible Preferred Stock Offering

Reuters
·
29 May

HeartSciences Inc. Reports Q3 FY2025 Results: No Revenues, Cash Reserves at $2.6 Million

Reuters
·
20 May

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

GlobeNewswire
·
01 May

HeartSciences Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
18 Mar

HeartSciences Cash And Cash Equivalents Were ~$2.6M As Of Jan. 31

Benzinga
·
14 Mar

Press Release: HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Dow Jones
·
14 Mar

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

GlobeNewswire
·
10 Mar

What Is Hedera? A Guide to the Open-Source Public Ledger

BE[IN]CRYPTO
·
26 Feb